Pnc Financial Services Group, Inc. Orchard Therapeutics PLC Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$5.75 - $11.99 $58,650 - $122,298	-10,200 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$5.65 - $15.71 $2,599 - $7,226	460 Added 4.72%	10,200 $76,000
Q4 2019 Feb 07, 2020	SELL	$10.15 - $15.58 $4,872 - $7,478	-480 Reduced 4.7%	9,740 $133,000
Q3 2019 Nov 08, 2019	BUY	$11.88 - $16.72 $4,039 - $5,684	340 Added 3.44%	10,220 $121,000
Q2 2019 Aug 09, 2019	BUY	$13.2 - $20.63 $44,088 - $68,904	3,340 Added 51.07%	9,880 $0
Q1 2019 May 10, 2019	BUY	$12.01 - $19.49 $78,545 - $127,464	6,540 New	6,540 $0

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.